Parkinson's Disease Trial, Recruiting NCT05962489 Sponsor: University of Minnesota Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05962489
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic Parkinson's disease (Parkinson's disease with no known outside cause)
  • People who are at least 21 years old
  • People who have already had, or are planned to have, a specific type of brain scan called a 7T MRI
  • People who are scheduled to have a deep brain stimulation (DBS) device surgically implanted in a specific area of the brain (called the GPi or STN) at the University of Minnesota, using a particular type of lead (directional leads), as part of their normal medical care
  • People who are scheduled to have this DBS device implanted on both sides of the brain, or who have already had the surgery, as long as their first programming appointment is still at least 2 weeks away

Who may not be able to join:

  • People who have another significant neurological condition (a condition affecting the brain or nervous system) in addition to Parkinson's disease
  • People with a history of dementia
  • People who experience certain complications or side effects after surgery that could affect their safety or interfere with the study results
  • People who are pregnant
  • People who have had significant radiation exposure in the past year, where adding the radiation from a procedure used during surgery (called intraoperative fluoroscopy) would be considered unsafe

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 612-625-4947

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 June 2023
Est. completion
1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

pallidopeduncular and pedunculopallidal pathway activation; pallidopeduncular and pedunculopallidal pathway activation; GPe activation; GPe activation; Actigraphy; Actigraphy; Clinical Rating Scales; Clinical Rating Scales

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov